Skip to content

Clinical trials

Hypoglycemia trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoglycemia Country / region: Saudi Arabia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20181
20191
20201
20213
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King Abdullah International Medical Research Center3
Dasman Diabetes Institute1
Eli Lilly and Company1
Ministry of Health, Saudi Arabia1
Novartis Pharmaceuticals1
Qassim University1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoglycemia9
Diabetes Mellitus, Type 13
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Insulin Resistance2
COVID-191
Diabetes Complications1
Disease Progression1
Fetal Growth Retardation1
Fetal Macrosomia1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.